Home
Jeff Radwell is an author, entrepreneur, and scientist, known for his multidisciplinary expertise spanning molecular genetics, cancer immunology, computational biology, and AI-driven innovation. His achievements across the life and mathematical sciences have solidified his reputation in both academia and industry, while his experimental research in cancer biology has been recognized through his lectureships at Imperial College London and New York University Grossman School of Medicine.
Jeff’s academic journey includes graduating summa cum laude from the University of Pennsylvania, earning an MBA from London Business School with First Class Honors, and completing his PhD at Imperial College London. His involvement in the Philomathean Society, the oldest collegiate literary society in the United States, reflects his connection to literary pursuits alongside his scientific and entrepreneurial endeavors. Radwell was also a standout athlete at Penn, playing Rugby Union as a lock, leveraging strength, agility, and tactics to secure line-out dominance in one of the most physically demanding positions on the field.
Beyond pure scholarly research, Jeff has been honored multiple times by the National Institutes of Health (NIH) as a distinguished scholar and has been recognized by New York University for his exceptional contributions to teaching, research, and inclusion. His dedication to Diversity, Equity, and Inclusion (DEI) is reflected in his leadership as co-founder of the Justice, Diversity, Equity, and Inclusion Group of the American Statistical Association. He also serves on the Board of Directors for the Federation of American Societies for Experimental Biology (FASEB), where he helps shape policies that advance research and scientific collaboration across disciplines. He actively advocates for representation in science, technology, and education, ensuring that opportunities are accessible, equitable, and diverse. As CEO of Camouflet, Jeff continues to champion diversity and inclusivity at a pivotal moment when industry leaders are turning away from such efforts.